EVALUATE GERIATRIC CANCER PATIENTS’S PERFORMANCE BY G8 QUESTIONNAIRES

Trần Bảo Ngọc; Vũ Bích Huyền

doi:10.34238/tnu-jst.5253

EVALUATE GERIATRIC CANCER PATIENTS’S PERFORMANCE BY G8 QUESTIONNAIRES

About this article

Received: 14/11/21 Revised: 20/01/22 Published: 25/01/22

Authors

1. Tran Bao Ngoc , TNU – University of Medicine and Pharmacy
2. Vu Bich Huyen, Thai Nguyen National Hospital

Abstract

This study aims to describe geriatric cancer patients’s performance at Thai Nguyen Oncology Center by G8 questionnaires. Research subjects were 132 cancer patients over 70 years old who is newly treated at Thai Nguyen Oncology Center from January 2021 to October 2021. Cross-sectional descriptive method. The G8 tool has 7 main items, scored 0-2 each, and divided into 3 groups: normal (14.5-17), moderate (11-14) and low (0-10.5). Mean age is 75; male/female ratio is 1.9/1; 85.6% stage IV; Cancer in the lung, breast, colon is accounted the highest; 62.9% for palliative care treatment alone, 9.1% for radical treatment. G8 scores range from 2 to 17 (median of 12); only 22.7% has normal G8 scores (14-17 points). Age group under 80; PS index 0, 1; Charlson index 0; Disease stage II/III had a normal level G8 score than the corresponding group (p<0.05). Comparison of G8 scores is better in breast cancer patients than lung cancer patients (p<0.05). Using the G8 questionnaire is valuable in describing the overall status of elderly cancer patients.

Keywords

Performance; G8; Questionnaires; Cancer; Geriatric

Full Text:

##common.remote## (Tiếng Việt) PDF (Tiếng Việt)

References

[1] M. Extermann, M. Aapro, R. Bernabei, H. J. Cohen, J. P. Droz, S. Lichtman, V. Mor, S. Monfardini, L. Repetto, L. Sorbye, and E. Topinkova, "Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)," Crit Rev Oncol Hematol, vol. 55, no. 3, pp. 241-52, 2005, doi: 10.1016/j.critrevonc.2005.06.003.

[2] L. Balducci and J. Yates, "General guidelines for the management of older patients with cancer," Oncology (Williston Park), vol. 14, no. 11A, pp. 221-227, 2000.

[3] L. Repetto, L. Biganzoli, C. H. Koehne, A. S. Luebbe, P. Soubeyran, V. C. Tjan-Heijnen, and M. S. Aapro, "EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer," Eur J Cancer, vol. 39, no. 16, pp. 2264-72, 2003, doi: 10.1016/s0959-8049(03)00662-2.

[4] P. Soubeyran, C. Bellera, J. Goyard, D. Heitz, H. Cure, H. Rousselot, G. Albrand, V. Servent, O. S. Jean, I. van Praagh, J. E. Kurtz, S. Perin, J. L. Verhaeghe, C. Terret, C. Desauw, V. Girre, C. Mertens, S. Mathoulin-Pelissier, and M. Rainfray, "Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study," PLoS One, vol. 9, no. 12, pp. e115060, 2014, doi: 10.1371/journal.pone.0115060.

[5] I. C. van Walree, E. Scheepers, L. van Huis-Tanja, M. H. Emmelot-Vonk, C. Bellera, P. Soubeyran, and M. E. Hamaker, "A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer," J Geriatr Oncol, vol. 10, no. 6, pp. 847-858, 2019, doi: 10.1016/j.jgo.2019.04.016.

[6] M. E. Charlson, P. Pompei, K. L. Ales, and C. R. MacKenzie, "A new method of classifying prognostic comorbidity in longitudinal studies: development and validation," J Chronic Dis, vol. 40, no. 5, pp. 373-383, 1987, doi: 10.1016/0021-9681(87)90171-8.

[7] M. Takahashi, M. Takahashi, K. Komine, H. Yamada, Y. Kasahara, S. Chikamatsu, A. Okita, S. Ito, K. Ouchi, Y. Okada, H. Imai, K. Saijo, H. Shirota, S. Takahashi, T. Mori, H. Shimodaira, and C. Ishioka, "The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study," PLoS One, vol. 12, no. 6, pp. e0179694, 2017, doi: 10.1371/journal.pone.0179694.

[8] C. A. Bellera, M. Rainfray, S. Mathoulin-Pelissier, C. Mertens, F. Delva, M. Fonck, and P. L. Soubeyran, "Screening older cancer patients: first evaluation of the G-8 geriatric screening tool," Ann Oncol, vol. 23, no. 8, pp. 2166-2172, 2012, doi. 10.1093/annonc/mdr587.

[9] M. E. Hamaker, M. Mitrovic, and R. Stauder, "The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy," Ann Hematol, vol. 93, no. 6, pp. 1031-1040, 2014, doi: 10.1007/s00277-013-2001-0.

[10] C. Kenis, L. Decoster, K. Van Puyvelde, J. De Greve, G. Conings, K. Milisen, J. Flamaing, J. P. Lobelle, and H. Wildiers, "Performance of two geriatric screening tools in older patients with cancer," J Clin Oncol, vol. 32, no. 1, pp. 19-26, 2014, doi: 10.1200/JCO.2013.51.1345.

[11] N. Denewet, S. De Breucker, S. Luce, B. Kennes, S. Higuet, and T. Pepersack, "Comprehensive geriatric assessment and comorbidities predict survival in geriatric oncology," Acta Clin Belg, vol. 71, no. 4, pp. 206-213, 2016, doi: 10.1080/17843286.2016.1153816.

DOI: https://doi.org/10.34238/tnu-jst.5253

Refbacks

There are currently no refbacks.



Remember me